Range Cancer Therapeutics ETF Holdings
CNCR was created on 2015-10-13 by Range. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 7.66m in AUM and 68 holdings. CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products.
Last Updated: 1 day, 5 hours ago
Last reported holdings - Range Cancer Therapeutics ETF
| Ticker | Name | Est. Value |
|---|---|---|
|
SMMT
|
Summit Therapeutics Inc Ordinary Shares | $155985 |
|
IPHA
|
Innate Pharma SA ADR | $149350 |
|
BPMC
|
Blueprint Medicines Corp | $136585 |
|
RVMD
|
Revolution Medicines Inc Ordinary Shares | $136417 |
|
FATE
|
Fate Therapeutics Inc | $135785 |
|
STRO
|
Sutro Biopharma Inc | $130926 |
|
DNA
|
Ginkgo Bioworks Holdings Inc | $129029 |
|
TSVT
|
2seventy bio Inc Ordinary Shares | $128675 |
|
SDGR
|
Schrodinger Inc Ordinary Shares | $128188 |
|
NUVB
|
Nuvation Bio Inc Ordinary Shares - Class A | $127997 |
|
IMCR
|
Immunocore Holdings PLC ADR | $126339 |
|
EXEL
|
Exelixis Inc | $125596 |
|
FHTX
|
Foghorn Therapeutics Inc Ordinary Shares | $125449 |
|
HCM
|
HUTCHMED (China) Ltd ADR | $122340 |
|
ERAS
|
Erasca Inc | $121279 |
|
IDYA
|
IDEAYA Biosciences Inc | $121061 |
|
BNTX
|
BioNTech SE ADR | $119707 |
|
TYRA
|
Tyra Biosciences Inc | $119440 |
|
GMAB
|
Genmab AS ADR | $118928 |
|
RCUS
|
Arcus Biosciences Inc | $118755 |
|
NUVL
|
Nuvalent Inc Class A | $118426 |
|
SWTX
|
SpringWorks Therapeutics Inc Ordinary Shares | $118087 |
|
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | $115964 |
|
MRUS
|
Merus NV | $115393 |
|
ZYME
|
Zymeworks Inc Registered Shs | $114626 |
|
KYMR
|
Kymera Therapeutics Inc Ordinary Shares | $113634 |
|
ELVN
|
Enliven Therapeutics Inc | $112805 |
|
IMTX
|
Immatics NV Ordinary Shares | $111017 |
|
CGEM
|
Cullinan Therapeutics Inc | $109611 |
|
RLAY
|
Relay Therapeutics Inc Ordinary Shares | $108879 |
|
YMAB
|
Y-mAbs Therapeutics Inc | $108118 |
|
IOVA
|
Iovance Biotherapeutics Inc | $107973 |
|
LEGN
|
Legend Biotech Corp ADR | $107590 |
|
SNDX
|
Syndax Pharmaceuticals Inc | $107557 |
|
JANX
|
Janux Therapeutics Inc Ordinary Shares | $106614 |
|
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | $105437 |
|
KURA
|
Kura Oncology Inc | $104844 |
|
BCYC
|
Bicycle Therapeutics PLC ADR | $104410 |
|
MRK
|
Merck & Co Inc | $104362 |
|
REGN
|
Regeneron Pharmaceuticals Inc | $102962 |
|
INBX
|
Inhibrx Biosciences Inc | $102894 |
|
ARVN
|
Arvinas Inc | $99712 |
|
BMY
|
Bristol-Myers Squibb Co | $99526 |
|
DAWN
|
Day One Biopharmaceuticals Inc | $99325 |
|
CRBU
|
Caribou Biosciences Inc Ordinary Shares | $98662 |
|
ACLX
|
Arcellx Inc | $98511 |
|
AURA
|
Aura Biosciences Inc | $97991 |
|
GNLX
|
Genelux Corp | $97333 |
|
PGEN
|
Precigen Inc | $96614 |
|
CMPX
|
Compass Therapeutics Inc Ordinary Shares | $96488 |
|
AUTL
|
Autolus Therapeutics PLC ADR | $94491 |
|
GERN
|
Geron Corp | $92246 |
|
IBRX
|
ImmunityBio Inc Ordinary Shares | $91492 |
|
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | $90990 |
|
MGNX
|
Macrogenics Inc | $89988 |
|
BMEA
|
Biomea Fusion Inc | $88462 |
|
NRIX
|
Nurix Therapeutics Inc Ordinary Shares | $88158 |
|
XNCR
|
Xencor Inc | $86265 |
|
ZNTL
|
Zentalis Pharmaceuticals Inc Ordinary Shares | $84925 |
|
REPL
|
Replimune Group Inc | $84025 |
|
RXRX
|
Recursion Pharmaceuticals Inc Class A | $81759 |
|
ALLO
|
Allogene Therapeutics Inc | $81252 |
|
FGXXX
|
First American Government Obligs X | $80932 |
|
GLUE
|
Monte Rosa Therapeutics Inc | $79876 |
|
TNGX
|
Tango Therapeutics Inc | $71860 |
|
ACRV
|
Acrivon Therapeutics Inc | $27330 |
|
VOR
|
Vor Biopharma Inc Ordinary Shares | $23692 |
|
None
|
DEPOSITS WITH BROKER FOR SHORT POSITIONS | $-1236 |
Recent Changes - Range Cancer Therapeutics ETF
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2025-03-26 |
KPTI
|
Karyopharm Therapeutics Inc | 13,708 |
| 2025-03-26 |
KPTI
|
Karyopharm Therapeutics Inc | -13,708 |
| 2025-03-07 |
KPTI
|
Karyopharm Therapeutics Inc | -13,708 |
| 2025-03-07 |
KPTI
|
Karyopharm Therapeutics Inc | 13,708 |
| 2024-11-21 |
EXAI
|
Exscientia PLC ADR | -33,095 |
| 2024-06-12 |
DCPH
|
Deciphera Pharmaceuticals Inc | -14,673 |
| 2024-06-10 |
MOR
|
MorphoSys AG ADR | -12,828 |
| 2024-05-30 |
INBX
|
Inhibrx Inc Ordinary Shares | -6,487 |
| 2024-04-12 |
AGEN
|
Agenus Inc | -478,611 |
| 2024-04-12 |
AGEN
|
Agenus Inc | 23,931 |
| 2024-02-13 |
IMGN
|
Immunogen Inc | -9,284 |
| 2024-02-13 |
THRX
|
Theseus Pharmaceuticals Inc | -50,498 |
| 2024-01-23 |
MRTX
|
Mirati Therapeutics Inc | -4,242 |
| 2023-12-21 |
VECT
|
VectivBio Holding AG | -8,512 |
| 2023-12-14 |
SGEN
|
Seagen Inc Ordinary Shares | -665 |
| 2023-11-10 |
EQRX
|
EQRx Inc | -62,415 |
| 2023-11-01 |
FGXXX
|
First American Government Obligs X | 27,998 |
| 2023-10-19 |
AMAM
|
Ambrx Biopharma Inc | 11,204 |
| 2023-09-12 |
FGXXX
|
First American Government Obligs X | 4,997 |
| 2023-09-08 |
FGXXX
|
First American Government Obligs X | -1,042 |
| 2023-08-16 |
FGXXX
|
First American Government Obligs X | 1,031 |
| 2023-06-21 |
FGXXX
|
First American Government Obligs X | 26,427 |
| 2023-05-11 |
FGXXX
|
First American Government Obligs X | 15,625 |
| 2023-05-09 |
FGXXX
|
First American Government Obligs X | -778 |
| 2023-05-09 |
INKT
|
MiNK Therapeutics Inc | -3,352 |
| 2023-04-26 |
INKT
|
MiNK Therapeutics Inc | 3,642 |
| 2023-02-14 |
FGXXX
|
First American Government Obligs X | 15,548 |
| 2023-02-09 |
FGXXX
|
First American Government Obligs X | -11,489 |
| 2022-12-22 |
FGXXX
|
First American Government Obligs X | -6,091 |
| 2022-12-21 |
JANX
|
Janux Therapeutics Inc Ordinary Shares | 57,680 |
| 2022-12-21 |
TIL
|
Instil Bio Inc | -134,859 |
| 2022-12-21 |
CELU
|
Celularity Inc Ordinary Shares - Class A | -159,964 |
| 2022-12-21 |
IMAB
|
I-MAB ADR | -68,752 |
| 2022-12-21 |
NGM
|
NGM Biopharmaceuticals Inc | -51,478 |
| 2022-12-21 |
NKTX
|
Nkarta Inc Ordinary Shares | -56,181 |
| 2022-12-21 |
NKTR
|
Nektar Therapeutics | -199,479 |
| 2022-12-21 |
AZN
|
AstraZeneca PLC ADR | -11,066 |
| 2022-12-21 |
INBX
|
Inhibrx Inc Ordinary Shares | 26,143 |
| 2022-12-21 |
BCYC
|
Bicycle Therapeutics PLC ADR | 23,426 |
| 2022-12-21 |
IMTX
|
Immatics NV Ordinary Shares | 78,683 |
| 2022-12-21 |
AGEN
|
Agenus Inc | 300,224 |
| 2022-12-21 |
RAPT
|
RAPT Therapeutics Inc Ordinary Shares | 40,947 |
| 2022-12-21 |
MRNA
|
Moderna Inc | 3,534 |
| 2022-08-08 |
FGXXX
|
First American Government Obligs X | -16,749 |
| 2022-07-15 |
LEGN
|
Legend Biotech Corp ADR | -515 |
| 2022-07-15 |
ALLO
|
Allogene Therapeutics Inc | -2,322 |
| 2022-07-15 |
RCUS
|
Arcus Biosciences Inc | -1,036 |
| 2022-07-15 |
MRUS
|
Merus NV | -1,138 |
| 2022-07-15 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -4,723 |
| 2022-07-15 |
NKTR
|
Nektar Therapeutics | -6,649 |
| 2022-07-15 |
IGMS
|
IGM Biosciences Inc Ordinary Shares | -1,579 |
| 2022-07-15 |
IMAB
|
I-MAB ADR | -2,292 |
| 2022-07-15 |
BNTX
|
BioNTech SE ADR | -162 |
| 2022-07-15 |
CELU
|
Celularity Inc Ordinary Shares - Class A | -5,332 |
| 2022-07-15 |
NKTX
|
Nkarta Inc Ordinary Shares | -1,873 |
| 2022-07-15 |
AZN
|
AstraZeneca PLC ADR | -369 |
| 2022-07-15 |
ACLX
|
Arcellx Inc | -1,279 |
| 2022-07-15 |
TIL
|
Instil Bio Inc | -4,495 |
| 2022-06-27 |
FGXXX
|
First American Government Obligs X | -19,735 |
| 2022-06-24 |
FGXXX
|
First American Government Obligs X | 61,465 |
| 2022-06-22 |
IBRX
|
ImmunityBio Inc Ordinary Shares | 7,545 |
| 2022-06-22 |
XNCR
|
Xencor Inc | 155 |
| 2022-06-22 |
IMAB
|
I-MAB ADR | 46,949 |
| 2022-06-22 |
LEGN
|
Legend Biotech Corp ADR | -12,040 |
| 2022-06-22 |
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | 7,853 |
| 2022-06-22 |
RCUS
|
Arcus Biosciences Inc | 2,129 |
| 2022-06-22 |
BGNE
|
BeiGene Ltd ADR | 741 |
| 2022-06-22 |
NKTR
|
Nektar Therapeutics | 116,831 |
| 2022-06-22 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | 146,425 |
| 2022-06-22 |
IOVA
|
Iovance Biotherapeutics Inc | 18,144 |
| 2022-06-22 |
REPL
|
Replimune Group Inc | 301 |
| 2022-06-22 |
ALLO
|
Allogene Therapeutics Inc | -7,790 |
| 2022-06-22 |
BCYC
|
BICYCLE THERAPEUTICS PLC ADR ADR USD.01 | -22,043 |
| 2022-06-22 |
ATRA
|
ATARA BIOTHERAPEUTICS INC | -77,289 |
| 2022-06-22 |
ALXO
|
ALX Oncology Holdings Inc. | -51,619 |
| 2022-06-22 |
ACLX
|
Arcellx Inc | 39,644 |
| 2022-06-22 |
ARGX
|
argenx SE ADR | -1,958 |
| 2022-06-22 |
BMY
|
Bristol-Myers Squibb Co | -9,505 |
| 2022-06-22 |
AZN
|
AstraZeneca PLC ADR | -9,528 |
| 2022-06-22 |
TIL
|
Instil Bio Inc | 68,031 |
| 2022-06-22 |
GILD
|
Gilead Sciences Inc | -4,637 |
| 2022-06-22 |
NKTX
|
Nkarta Inc Ordinary Shares | 58,054 |
| 2022-06-22 |
BNTX
|
BioNTech SE ADR | 5,019 |
| 2022-06-22 |
REGN
|
Regeneron Pharmaceuticals Inc | -633 |
| 2022-06-22 |
INBX
|
Inhibrx Inc. | -27,748 |
| 2022-06-22 |
CRBU
|
Caribou Biosciences Inc. | -74,528 |
| 2022-06-22 |
IGMS
|
IGM Biosciences Inc Ordinary Shares | 48,946 |
| 2022-06-22 |
GMAB
|
Genmab A/S ADR | -6,479 |
| 2022-06-22 |
IMCR
|
Immunocore Holdings PLC ADR | -14,992 |
| 2022-06-22 |
MRK
|
Merck & Co Inc | -7,475 |
| 2022-06-22 |
CELU
|
Celularity Inc Ordinary Shares - Class A | 165,296 |
| 2022-06-22 |
NGM
|
NGM Biopharmaceuticals Inc | 53,194 |
| 2022-06-22 |
RUBY
|
Rubius Therapeutics Inc. | -93,711 |
| 2022-06-22 |
MGNX
|
MACROGENICS INC | -71,363 |
| 2022-06-22 |
FATE
|
Fate Therapeutics Inc | 12,875 |
| 2022-06-21 |
MRUS
|
MERUS BV | 23,496 |
| 2022-06-13 |
MRUS
|
Merus NV | 2,395 |
| 2022-06-13 |
ATRA
|
Atara Biotherapeutics Inc | 4,940 |
| 2022-06-13 |
TIL
|
Instil Bio Inc | 4,368 |
| 2022-06-13 |
BGNE
|
BeiGene Ltd ADR | 276 |
| 2022-06-13 |
CRBU
|
Caribou Biosciences Inc Ordinary Shares | 4,574 |
| 2022-06-13 |
INBX
|
Inhibrx Inc Ordinary Shares | 1,706 |
| 2022-06-13 |
REGN
|
Regeneron Pharmaceuticals Inc | 124 |
| 2022-06-13 |
ALXO
|
ALX Oncology Holdings Inc Ordinary Shares | 3,167 |
| 2022-06-13 |
LEGN
|
Legend Biotech Corp ADR | 1,798 |
| 2022-06-13 |
MGNX
|
Macrogenics Inc | 4,370 |
| 2022-06-13 |
IBRX
|
ImmunityBio Inc Ordinary Shares | 13,378 |
| 2022-06-13 |
CRSP
|
CRISPR Therapeutics AG | 940 |
| 2022-06-13 |
RCUS
|
Arcus Biosciences Inc | 1,842 |
| 2022-06-13 |
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | 1,832 |
| 2022-06-13 |
XNCR
|
Xencor Inc | 1,992 |
| 2022-06-13 |
IMCR
|
Immunocore Holdings PLC ADR | 2,304 |
| 2022-06-13 |
BMY
|
Bristol-Myers Squibb Co | 1,220 |
| 2022-06-13 |
MRK
|
Merck & Co Inc | 1,104 |
| 2022-06-13 |
ARGX
|
argenx SE ADR | 255 |
| 2022-06-13 |
GILD
|
Gilead Sciences Inc | 1,176 |
| 2022-06-13 |
AZN
|
AstraZeneca PLC ADR | 1,609 |
| 2022-06-13 |
NKTR
|
Nektar Therapeutics | 5,480 |
| 2022-06-09 |
FGXXX
|
First American Government Obligs X | -14,122 |
| 2022-05-24 |
MRUS
|
MERUS BV | 22,041 |
| 2022-05-23 |
MRUS
|
MERUS BV | 22,041 |
| 2022-05-11 |
MRUS
|
MERUS BV | 22,041 |
| 2022-05-10 |
FGXXX
|
FIRST AMERN FDS INC GOVT OBLIGS X | -16,565 |
| 2022-05-06 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-28 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-22 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-13 |
FGXXX
|
First American Government Obligs X | -17,994 |
| 2022-04-11 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-08 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-05 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-04 |
MRUS
|
MERUS BV | 22,041 |
| 2022-04-01 |
REPL
|
REPLIMUNE GROUP INC | -1,503 |
| 2022-04-01 |
BMY
|
BRISTOL-MYERS SQUIBB CO | -613 |
| 2022-04-01 |
CRBU
|
Caribou Biosciences Inc. | -2,412 |
| 2022-04-01 |
ALXO
|
ALX Oncology Holdings Inc. | -1,671 |
| 2022-04-01 |
IMAB US
|
I-MAB IMAB | -780 |
| 2022-04-01 |
GMXAY
|
GENMAB A/S -SP ADR | -1,019 |
| 2022-04-01 |
REGN
|
REGENERON PHARMACEUTICALS | -60 |
| 2022-04-01 |
RCUS
|
Arcus Biosciences Inc. | -971 |
| 2022-04-01 |
MRK
|
MERCK & CO. INC. | -502 |
| 2022-04-01 |
MGNX
|
MACROGENICS INC | -2,310 |
| 2022-04-01 |
LEGN
|
LEGEND BIOTECH CORP-ADR | -904 |
| 2022-04-01 |
ITOS
|
iTeos Therapeutics Inc. | -966 |
| 2022-04-01 |
MRUS
|
MERUS BV | 21,541 |
| 2022-04-01 |
XNCR
|
XENCOR INC | -1,051 |
| 2022-04-01 |
BCYC
|
BICYCLE THERAPEUTICS PLC ADR ADR USD.01 | -713 |
| 2022-04-01 |
GILD
|
GILEAD SCIENCES INC | -528 |
| 2022-04-01 |
FATE
|
FATE THERAPEUTICS INC | -740 |
| 2022-04-01 |
CRSP
|
CRISPR THERAPEUTICS AG | -500 |
| 2022-04-01 |
AZN
|
ASTRAZENECA PLC-SPONS ADR | -667 |
| 2022-03-31 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-29 |
FGXXX
|
First American Government Obligs X | 19,321 |
| 2022-03-28 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-25 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-15 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-14 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-11 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-10 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-09 |
MRUS
|
MERUS BV | 22,801 |
| 2022-03-07 |
FGXXX
|
First American Government Obligs X | -16,798 |
| 2022-03-01 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-28 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-25 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-22 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-16 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-15 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-14 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-09 |
MRUS
|
MERUS BV | 22,801 |
| 2022-02-08 |
LEGN
|
LEGEND BIOTECH CORP-ADR | 904 |
| 2022-02-08 |
GMXAY
|
GENMAB A/S -SP ADR | 1,019 |
| 2022-02-08 |
IBRX
|
IMMUNITYBIO INC COMMON STOCK USD.0001 | 6,719 |
| 2022-02-08 |
IMAB US
|
I-MAB IMAB | 780 |
| 2022-02-08 |
ALLO
|
ALLOGENE THERAPEUTICS INC | 2,582 |
| 2022-02-08 |
INBX
|
Inhibrx Inc. | 898 |
| 2022-02-08 |
IMCR
|
IMMUNOCORE HOLDINGS ADR PLC | 1,227 |
| 2022-02-08 |
XNCR
|
XENCOR INC | 1,051 |
| 2022-02-08 |
BGNE
|
BEIGENE LTD-ADR | 140 |
| 2022-02-08 |
TIL
|
Instil Bio Inc. | 2,309 |
| 2022-02-08 |
MRUS
|
MERUS BV | 23,301 |
| 2022-02-08 |
ITOS
|
iTeos Therapeutics Inc. | 966 |
| 2022-02-08 |
NKTR
|
NEKTAR THERAPEUTICS | 2,890 |
| 2022-02-08 |
MGNX
|
MACROGENICS INC | 2,310 |
| 2022-02-08 |
CRBU
|
Caribou Biosciences Inc. | 2,412 |
| 2022-02-08 |
ARGX
|
ARGENX SE | 128 |
| 2022-02-07 |
MRUS
|
MERUS BV | 22,041 |
| 2022-02-04 |
RUBY
|
Rubius Therapeutics Inc. | 6,066 |
| 2022-02-04 |
GILD
|
GILEAD SCIENCES INC | 1,056 |
| 2022-02-04 |
CRBU
|
Caribou Biosciences Inc. | 4,824 |
| 2022-02-04 |
IBRX
|
IMMUNITYBIO INC COMMON STOCK USD.0001 | 12,887 |
| 2022-02-04 |
REGN
|
REGENERON PHARMACEUTICALS | 118 |
| 2022-02-04 |
MRK
|
MERCK & CO. INC. | 965 |
| 2022-02-04 |
MGNX
|
MACROGENICS INC | 4,620 |
| 2022-02-04 |
LEGN
|
LEGEND BIOTECH CORP-ADR | 1,735 |
| 2022-02-04 |
ITOS
|
iTeos Therapeutics Inc. | 1,932 |
| 2022-02-04 |
IOVA
|
IOVANCE BIOTHERAPEUTICS INC | 4,094 |
| 2022-02-04 |
ALXO
|
ALX Oncology Holdings Inc. | 3,342 |
| 2022-02-04 |
GMXAY
|
GENMAB A/S -SP ADR | 2,038 |
| 2022-02-04 |
AZN
|
ASTRAZENECA PLC-SPONS ADR | 1,283 |
| 2022-02-04 |
ARGX
|
ARGENX SE | 244 |
| 2022-02-04 |
BGNE
|
BEIGENE LTD-ADR | 280 |